These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of lipid-lowering agents in the management of diabetic retinopathy. Ioannidou E; Tseriotis VS; Tziomalos K World J Diabetes; 2017 Jan; 8(1):1-6. PubMed ID: 28138358 [TBL] [Abstract][Full Text] [Related]
24. Screening for and managing diabetic retinopathy: current approaches. Bloomgarden ZT Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S8-14. PubMed ID: 17720893 [TBL] [Abstract][Full Text] [Related]
25. Fenofibrate for the prevention of progression of non-proliferative diabetic retinopathy: review, consensus recommendations and guidance for clinical practice. Ngah NF; Muhamad NA; Abdul Aziz RA; Mohamed SO; Ahmad Tarmizi NA; Adnan A; Asnir ZZ; Hussein Z; Siew HF; Mohamed M; Lodz NA; Valayatham V Int J Ophthalmol; 2022; 15(12):2001-2008. PubMed ID: 36536974 [TBL] [Abstract][Full Text] [Related]
26. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Ciulla TA; Amador AG; Zinman B Diabetes Care; 2003 Sep; 26(9):2653-64. PubMed ID: 12941734 [TBL] [Abstract][Full Text] [Related]
27. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy]. Vorob'eva IV Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427 [TBL] [Abstract][Full Text] [Related]
28. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy. Koleva-Georgieva DN; Sivkova NP Folia Med (Plovdiv); 2010; 52(1):40-8. PubMed ID: 20380286 [TBL] [Abstract][Full Text] [Related]
29. Fibrates and microvascular complications in diabetes--insight from the FIELD study. Ansquer JC; Foucher C; Aubonnet P; Le Malicot K Curr Pharm Des; 2009; 15(5):537-52. PubMed ID: 19199980 [TBL] [Abstract][Full Text] [Related]
30. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy. Kang EY; Chen TH; Garg SJ; Sun CC; Kang JH; Wu WC; Hung MJ; Lai CC; Cherng WJ; Hwang YS JAMA Ophthalmol; 2019 Apr; 137(4):363-371. PubMed ID: 30629109 [TBL] [Abstract][Full Text] [Related]
31. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region. Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994 [TBL] [Abstract][Full Text] [Related]
32. Importance of telemedicine in diabetes care: Relationships between family physicians and ophthalmologists. Romero-Aroca P; Sagarra-Alamo R; Pareja-Rios A; López M World J Diabetes; 2015 Jul; 6(8):1005-8. PubMed ID: 26240697 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus. Schreur V; van Asten F; Ng H; Weeda J; Groenewoud JMM; Tack CJ; Hoyng CB; de Jong EK; Klaver CCW; Jeroen Klevering B Acta Ophthalmol; 2018 Aug; 96(5):459-464. PubMed ID: 30188024 [TBL] [Abstract][Full Text] [Related]
34. Association of Bone Metabolic Markers With Diabetic Retinopathy and Diabetic Macular Edema in Elderly Chinese Individuals With Type 2 Diabetes Mellitus. Zhang X; Yang J; Zhong Y; Xu L; Wang O; Huang P; Li C; Qu B; Wang J; Zheng C; Niu M; Yu W Am J Med Sci; 2017 Oct; 354(4):355-361. PubMed ID: 29078839 [TBL] [Abstract][Full Text] [Related]
35. Retinal images benchmark for the detection of diabetic retinopathy and clinically significant macular edema (CSME). Noor-Ul-Huda M; Tehsin S; Ahmed S; Niazi FAK; Murtaza Z Biomed Tech (Berl); 2019 May; 64(3):297-307. PubMed ID: 30055096 [TBL] [Abstract][Full Text] [Related]
36. [Relationship between the classification of diabetic macular edema and its related factors]. Liu LY; Dong FT; Li H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):797-802. PubMed ID: 18595262 [TBL] [Abstract][Full Text] [Related]
37. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study. Kaewput W; Thongprayoon C; Rangsin R; Ruangkanchanasetr P; Mao MA; Cheungpasitporn W World J Nephrol; 2019 Feb; 8(2):33-43. PubMed ID: 30815379 [TBL] [Abstract][Full Text] [Related]
38. Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-A novel OCT based imaging biomarker. Gupta C; Tan R; Mishra C; Khandelwal N; Raman R; Kim R; Agrawal R; Sen P PLoS One; 2018; 13(12):e0207435. PubMed ID: 30533048 [TBL] [Abstract][Full Text] [Related]
39. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF]. Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789 [TBL] [Abstract][Full Text] [Related]
40. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Silva PS; Cavallerano JD; Sun JK; Noble J; Aiello LM; Aiello LP Am J Ophthalmol; 2012 Sep; 154(3):549-559.e2. PubMed ID: 22626617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]